Reuters: Hot Stocks: Ranbaxy shares slump after Daiichi Sankyo says misled over probes

Reuters: Hot Stocks Reuters.com is your source for breaking news, business, financial and investing news, including personal finance and stocks. Reuters is the leading global provider of news, financial information and technology solutions to the world's media, financial institutions, businesses and individuals. // via fulltextrssfeed.com

Ranbaxy shares slump after Daiichi Sankyo says misled over probes May 23rd 2013, 04:15 MUMBAI | Thu May 23, 2013 12:15am EDT MUMBAI May 23 (Reuters) - Ranbaxy Laboratories Ltd slumped as much as 6.6 percent on Thursday after majority shareholder Daiichi Sankyo Co said it believes former shareholders of the Indian company hid information regarding U.S. regulatory probes. "Daiichi Sankyo believes that certain former shareholders of Ranbaxy concealed and misrepresented critical information concerning the U.S. DOJ and FDA investigations," the Japanese company said in a statement on its website late on Wednesday, referring to the U.S. Department of Justice and the Food and Drug Administration. Daiichi Sankyo did not name the shareholders. Last week, Ranbaxy pleaded guilty to felony charges related to drug safety and agreed to pay $500 million in civil and criminal fines under a settlement with the U.S. Department of Justice. Ranbaxy shares were down 5.35 percent as of 0403 GMT, under-performing a 0.4 percent fall in the broader NSE index . (Reporting by Rafael Nam; Editing by Edwina Gibbs)

You are receiving this email because you subscribed to this feed at blogtrottr.com. If you no longer wish to receive these emails, you can unsubscribe from this feed, or manage all your subscriptions